 MONMOUTH JUNCTION, N.J., Feb. 16, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,... 